notice Published 2026-07-27

Certain Dermatological Treatment Devices and Components Thereof II; Notice of Institution of Investigation

📌 ETDETA brief — importer impact summary (educational)

Brief takeaway: The ITC has opened a Section 337 investigation into whether certain imported dermatological treatment devices infringe four U.S. patents, which could eventually lead to import restrictions.

What changed: According to the notice, a complaint was filed on June 22, 2026 (supplemented July 6 and 13, 2026) by Serendia, LLC, alleging that the importation and sale of certain dermatological treatment devices and components infringe claims of four U.S. patents. The notice states the complainant requests a limited exclusion order and cease and desist orders. Institution of an investigation is not a finding of violation.

Who's affected: The notice names certain dermatological treatment devices and components thereof. It cites U.S. Patent Nos. 9,320,536, 9,775,774, 10,869,812, and 12,220,549. No specific HTS codes or countries of origin are named in the notice.

What to review:
- Review whether your imported products could fall within the category of dermatological treatment devices or components described in the complaint.
- Confirm with your customs broker or trade counsel whether any final exclusion order, if issued later, may be relevant to your goods.
- Check the ITC docket for the accused products, respondents, and scope as the investigation proceeds.
- Review supply-chain and product documentation in case the complaint's patents are relevant to your merchandise.

This is general information, not legal advice and not a compliance determination — confirm specifics with a licensed customs broker or trade counsel.

Official notice

Notice is hereby given that a complaint was filed with the U.S. International Trade Commission on June 22, 2026, under section 337 of the Tariff Act of 1930, as amended, on behalf of Serendia, LLC of Los Angeles, California. Supplements were filed on July 6 and 13, 2026. The complaint, as supplemented, alleges violations of section 337 based upon the importation into the United States, the sale for importation, and the sale within the United States after importation of certain dermatological treatment devices and components thereof by reason of the infringement of certain claims of U.S. Patent No. 9,320,536 ("the '536 patent"); U.S. Patent No. 9,775,774 ("the '774 patent"); U.S. Patent No. 10,869,812 ("the '812 patent"); and U.S. Patent No. 12,220,549 ("the '549 patent"). The complaint, as supplemented, further alleges that an industry in the United States exists as required by the applicable Federal Statute. The complainant requests that the Commission institute an investigation and, after the investigation, issue a limited exclusion order and cease and desist orders.

Source: Federal Register · International Trade Commission · Read the official notice ↗

Check how this affects your product

Run a U.S. import compliance self-check → Check an HTS classification → Estimate duty & landed cost →

Need help moving this shipment?

ETDETA coordinates the logistics side of your U.S. import — booking, ocean freight, inland transportation, and customs-clearance coordination through licensed customs brokers.

Get a Full Freight Quote →

Related updates

This update is a general educational summary based on public CBP CSMS / Federal Register information. It is not legal advice, customs broker advice, a final classification, duty determination, entry instruction, or compliance determination. Importers should confirm applicability, effective dates, HTSUS/Chapter 99 reporting, rates, refunds, PSC procedures, and filing instructions with their licensed customs broker, trade counsel, and/or CBP.